Patent Application
Utility
App. No. 17/843,455
· Confirmation No. 6586
TRIAZOLE GLYCOLATE OXIDASE INHIBITORS
Inventors:
Hans MAAG, Miguel Xavier FERNANDES, Robert ZAMBONI, Elham AKBARIROMANI, Marc-Andre BEAULIEU, Yves LEBLANC, Pallavi THAKUR
Applicant:
CANTERO THERAPEUTICS, INC.
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2025-02-04 | ABN |
Abandonment | 2 | View | |
| 2024-12-20 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2024-12-20 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2024-11-22 | N570 |
Communication - Re: Power of Attorney (PTOL-308) | 1 | View | |
| 2024-11-18 | PA.. |
Power of Attorney | 2 | View | |
| 2024-11-18 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2024-07-01 | CTNF |
Non-Final Rejection | 8 | View | |
| 2024-07-01 | EXIN |
Examiner Interview Summary Record (PTOL - 413) | 1 | View | |
| 2024-07-01 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2024-07-01 | FWCLM |
Index of Claims | 2 | View | |
| 2024-07-01 | 1449 |
List of References cited by applicant and considered by examiner | 4 | View | |
| 2024-07-01 | SRNT |
Examiner's search strategy and results | 4 | View | |
| 2024-07-01 | 1449 |
List of References cited by applicant and considered by examiner | 1 | View | |
| 2024-06-18 | ELC. |
Response to Election / Restriction Filed | — | View | |
| 2024-06-18 | TRAN.LET |
Transmittal Letter | — | View | |
| 2024-06-18 | FOR |
Foreign Reference | 14 | View | |
| 2024-06-18 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2024-06-18 | ELC. |
Response to Election / Restriction Filed | 1 | View | |
| 2024-06-18 | CLM |
Claims | 7 | View | |
| 2024-06-18 | REM |
Applicant Arguments/Remarks Made in an Amendment | 2 | View | |
| 2024-06-18 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2024-06-18 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 1 | View | |
| 2024-06-18 | REF.OTHER |
Other reference-Patent/Application/Search Documents | 4 | View | |
| 2024-06-18 | FOR |
Foreign Reference | 105 | View | |
| 2024-06-18 | FOR |
Foreign Reference | 339 | View | |
| 2024-06-18 | REF.OTHER |
Other reference-Patent/Application/Search Documents | 9 | View | |
| 2024-06-18 | N417 |
Electronic Filing System Acknowledgment Receipt | 4 | View | |
| 2024-06-18 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2024-03-20 | CTRS |
Requirement for Restriction/Election | 6 | View | |
| 2024-03-20 | FWCLM |
Index of Claims | 2 | View | |
| 2024-03-20 | BIB |
Bibliographic Data Sheet | 2 | View | |
| 2024-02-13 | EXIN |
Examiner Interview Summary Record (PTOL - 413) | 2 | View | |
| 2023-05-11 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2023-01-03 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2023-01-03 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2022-12-27 | PEFR |
Applicant Response to Pre-Exam Formalities Notice | 2 | View | |
| 2022-12-27 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2022-12-27 | IDS.R197.REL |
Letter specifying the conditions for filing under 37 CFR 1.97 | 2 | View | |
| 2022-12-27 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 4 | View | |
| 2022-12-27 | A.PE |
Preliminary Amendment | 1 | View | |
| 2022-12-27 | CLM |
Claims | 16 | View | |
| 2022-12-27 | REM |
Applicant Arguments/Remarks Made in an Amendment | 2 | View | |
| 2022-12-27 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2022-12-27 | A.PE |
Preliminary Amendment | — | View | |
| 2022-06-30 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2022-06-30 | WCLM |
Claims Worksheet (PTO-2022) | 1 | View | |
| 2022-06-30 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2022-06-30 | NTC.MISS.PRT |
Notice to File Missing Parts | 2 | View | |
| 2022-06-17 | PA.. |
Power of Attorney | 1 | View | |
| 2022-06-17 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2022-06-17 | ADS |
Application Data Sheet | 11 | View | |
| 2022-06-17 | TRNA |
Transmittal of New Application | 1 | View | |
| 2022-06-17 | SPEC |
Specification | 126 | View | |
| 2022-06-17 | CLM |
Claims | 24 | View | |
| 2022-06-17 | ABST |
Abstract | 1 | View | |
| 2022-06-17 | DRW.NONBW |
Drawings-other than black and white line drawings | 1 | View | |
| 2022-06-17 | OATH |
Oath or Declaration filed | 7 | View | |
| 2022-06-17 | SCORE |
Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) | 1 | View | |
| 2022-06-17 | DRW.SUPP |
Drawings-black and white line and/or other drawings | — | View |
Inventors
Hans MAAG
Kleines Wiesental, GERMANY
Miguel Xavier FERNANDES
San Cristobal de La Laguna, SPAIN
Robert ZAMBONI
Beaconsfield, CANADA
Elham AKBARIROMANI
Laval, CANADA
Marc-Andre BEAULIEU
L'Assomption, CANADA
Yves LEBLANC
Kirkland, CANADA
Pallavi THAKUR
Montreal, CANADA
Attorneys & Agents of Record
Classification
USPC
548/255
C07D249/04
Prosecution
- Examiner
- NORTHINGTON DAVIS, ZINNA
- Art Unit
- RD00
- Customer No.
- 176569
- Docket No.
- 057068-502C01US
- Confirmation No.
- 6586
Publication
- Pub. No.
- US20230143491A1
- Pub. Date
- 2023-05-11
Parent
is a Continuation of
→
App. 17/255,600
· US 11,401,246
Filed 2020-12-23
· Patented Case
Parent
PCT
is a National Stage Entry of
→
PCT/US2019/040690
Filed 2019-07-05
· Abandoned -- Failure to Respond to an Office Action
Parent
Claims priority from a provisional application
→
App. 62/827,573
Filed 2019-04-01
· Provisional Application Expired
Parent
Claims priority from a provisional application
→
App. 62/694,918
Filed 2018-07-06
· Provisional Application Expired
Child
is a Continuation of
→
App. 18/991,216
Filed 2024-12-20
· Abandoned -- Incomplete Application (Pre-examination)
BRIDGEBIO PHARMA, INC.,
QED THERAPEUTICS, INC.,
EIDOS THERAPEUTICS, INC.,
ML BIO SOLUTIONS INC.,
CALCILYTIX THERAPEUTICS INC.,
ADRENAS THERAPEUTICS INC.,
PHOENIX TISSUE REPAIR, INC.,
NAVIRE PHARMA, INC.,
VENTHERA, INC.,
MOLECULAR SKIN THERAPEUTICS, INC.,
CANTERO THERAPEUTICS, INC.,
COA THERAPEUTICS, INC.,
PORTAL THERAPEUTICS, INC.,
BRIDGEBIO GENE THERAPY RESEARCH, INC.,
FERRO THERAPEUTICS, INC.
RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL
Recorded 2025-03-05
from
ADRENAS THERAPEUTICS INC.,
BRIDGEBIO GENE THERAPY RESEARCH, INC.,
BRIDGEBIO PHARMA, INC.,
CALCILYTIX THERAPEUTICS INC.,
CANTERO THERAPEUTICS, INC.,
COA THERAPEUTICS, INC.,
EIDOS THERAPEUTICS, INC.,
FERRO THERAPEUTICS, INC.,
ML BIO SOLUTIONS INC.,
MOLECULAR SKIN THERAPEUTICS, INC.,
NAVIRE PHARMA, INC.,
PHOENIX TISSUE REPAIR, INC.,
PORTAL THERAPEUTICS, INC.,
QED THERAPEUTICS, INC.,
SUB21, INC.,
THERAS, INC.,
VENTHERA, INC.
SECURITY INTEREST
Recorded 2024-01-19
from
ADRENAS THERAPEUTICS INC.,
BRIDGEBIO GENE THERAPY RESEARCH, INC.,
CALCILYTIX THERAPEUTICS INC.,
CANTERO THERAPEUTICS, INC.,
COA THERAPEUTICS, INC.,
FERRO THERAPEUTICS, INC.,
MOLECULAR SKIN THERAPEUTICS, INC.,
NAVIRE PHARMA, INC.,
PHOENIX TISSUE REPAIR, INC.,
PORTAL THERAPEUTICS, INC.,
SUB21, INC.,
VENTHERA, INC.
SECURITY INTEREST
Recorded 2024-01-17
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 17/843,455
- Filed
- 2022-06-17
- Pub. No.
- US20230143491A1
- Examiner
- NORTHINGTON DAVIS, ZINNA
- Art Unit
- RD00
External Links